Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Methanone, [(2S,3aS,7aS)-octahydro-1-[[(1R,2R)-2-phenylcyclopropyl]carbonyl]-1H-indol-2-yl]-3-thiazolidinyl- | 176797-26-5 | C22H28N2O2S | 50 MG
SDP

Catalog No. 5000375815
Encompass_Preferred

S 17092 (S 17092-1) is an orally active cerebral prolyl-endopeptidase (PEP) inhibitor with an IC50 of 1.2 nM. It inhibits cell apoptosis by slowing down the degradation of neuroactive peptides, thereby enhancing memory function. It is suitable for research on memory impairment and cognitive disorders associated with cerebral aging.

  • Orally active cerebral prolyl-endopeptidase (PEP) inhibitor
  • Inhibits cell apoptosis
  • Enhances memory function
  • Useful for research on memory impairment and cognitive disorders
  • Long-acting PEP inhibitor with a half-life of over 9 hours

Catalog No. 50-003-75815 Supplier Medchemexpress LLC Supplier No. HY1511450MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

S 17092 (S 17092-1) is an orally active cerebral prolyl-endopeptidase (PEP) inhibitor with an IC50 of 1.2 nM. It inhibits cell apoptosis by slowing down the degradation of neuroactive peptides, thereby enhancing memory function. It is suitable for research on memory impairment and cognitive disorders associated with cerebral aging.

  • Orally active cerebral prolyl-endopeptidase (PEP) inhibitor
  • Inhibits cell apoptosis
  • Enhances memory function
  • Useful for research on memory impairment and cognitive disorders
  • Long-acting PEP inhibitor with a half-life of over 9 hours

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.